Heron Therapeutics, Inc. · NASDAQ:HRTX

Duarte Ira exercised options for 25,229 Heron Therapeutics, Inc. shares (Form 4)

Traded Apr 30, 2026 · Filed May 4, 2026

On Apr 30, 2026, Duarte Ira (EVP, Chief Financial Officer) exercised options for 25,229 Heron Therapeutics, Inc. shares, leaving 252,128 shares. Filed May 4, 2026 (Form 4).

Options exercised
25,229 shares
Holding after
252,128 shares
Trading plan
No
Role
EVP, Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 30, 2026Common StockOption exercise11,694227,570Direct
Apr 30, 2026Common StockOption exercise13,535252,128Direct

Source

View original at SEC

Related